The failure rate for the approval of new drugs is bad, everyone knows that. But it may be worse than most everyone thought, writes Derek Lowe, who summarizes the latest data on drug success rates in the blog Corante.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: role for epigenetic in neuronal excitability, and more.
The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.
Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.
A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.